Provides product and service solutions for life science research

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.

Ningbo Aocheng Biotechnology Co., Ltd., established on 2009-02-16, Business scope includes general items:Biochemical product technology research and development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Class I Medical Device Leasing;software development;Artificial intelligence application software development;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Network and Information Security Software Development;Information system operation and maintenance services;Wholesale of computer software, hardware and auxiliary equipment;Medical Research and Experimental Development;Conference and Exhibition Services;Technology Import and Export;Import and export;market survey(Does not include foreign investigations);Bidding agency service;marketing planning;Mechanical Parts,Parts sales;Instrument sales;Machinery sales;electronics sales;Experimental analysis instrument sales;software sales;Office Supplies Sales;Glassware Sales;Sales of plastic products;Sales of technical glass products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III Medical Device Leasing;Class III medical device business;Production of Class III Medical Devices;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides. The company's first commercial product, the PacBio RS, was sold to a limited set of customers in 2010 and was commercially released in early 2011. A subsequent version of the sequencer called the PacBio RS II was released in April 2013. On 25 September 2013 a partnership between Pacific Biosciences and Roche Diagnostics was announced for the development of in vitro diagnostic products using the technology, with Roche providing US$75,000,000 in the deal. In 2015, the company launched a new sequencing instrument called the Sequel System with approximately 7-fold greater capacity than the PacBio RS II. Then in April 2019 the company launched the Sequel II system with a further 8-fold increase in throughput.

Alfasigma is a major group that has accepted an important challenge: finding solutions to cure the population each and every day. Alfasigma products are appreciated throughout the world. Technology, enthusiasm and specific expertise have ensured continuous growth and steady internationalization. Four graphics are presented below that illustrate the progress of the group in Italy and the world.

Shenzhen MGI Technology Co., Ltd., established on 2019-09-27, Business scope includes general business items:Medical equipment,medical instruments,Equipment,Instrumentation,Biochemical reagents,biological reagent,Sales of consumables and bioengineering related products(Hazardous chemicals are limited to the scope of the license,Commodities that do not involve state trade management,Quota involved,Commodities managed by license management and other special regulations,Apply in accordance with relevant national regulations);Industry application software technology development,and related technical advice,Technology Transfer and Technical Services(Free of restricted and prohibited items,Involving license management and other special regulation management,Operate only after obtaining a license);commission agent(except auction),Import and export and related supporting business(Commodities that do not involve state trade management,Quota involved,Commodities managed by license management and other special regulations,Apply in accordance with relevant national regulations),The licensing program is:

Xiamen Fushengyuan Biotechnology Co., Ltd., established on 2020-07-29, Business scope includes general items:Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;raw nuts,dried fruit sales;internet sales(Except for products that require a license for sale);Health Care Services(non-medical);Sales of agricultural and sideline products;Chinese herbal medicine acquisition;Retailing of Edible Agricultural Products;Daily necessities sales;electronics sales;Home Appliance Sales;Appliance Installation Services;Sales of household appliances spare parts;Sales of electrical accessories;Wholesale of hardware products;Sales of electrical machinery and equipment.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Health food sales;Food Internet Sales(Selling prepackaged food);Food Internet Sales;food business;food business(Selling prepackaged food).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Rohm and Haas Company is a manufacturer of speciality chemicals for end use markets such as building and construction, electronic devices, packaging, household and personal care products. Headquartered in Philadelphia, the company is organised into three business groups of Specialty Materials, Performance Materials and Electronic Materials, and also has two stand-alone businesses of Powder Coatings and Salt. Formerly a Fortune 500 Company, Rohm and Haas employs more than 17,000 people in 27 countries, with its last sales revenue reported as an independent company at US$8.9 billion. Dow Chemical Company bought Rohm and Haas for $15 billion in 2009.

Dynamiker Biotechnology provides research, development, production, clinical application, and technical support for the diagnosis of Invasive fungal diseases. They supply all products for IFD panel testing. They build an eco-industrial chain for diagnosing and managing IFDs.

Kangma (Shanghai) Biotechnology Co., Ltd., established on 2015-10-20, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of bio-based materials;Instrument sales;Sales of bio-based materials;Sales of Class I Medical Devices;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Tianjin Hongyutai Biotechnology Co., Ltd., established on 2020-08-04, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Health Consulting Services(Does not include medical services);Medical equipment rental;Machinery and Equipment Leasing;Sales of office equipment consumables;Wholesale of computer software, hardware and auxiliary equipment;Transport cargo packing service;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);Medical Research and Experimental Development;Domestic Freight Forwarding.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Technology Import and Export;Import and export;Import and export agency;pharmaceutical production;Drug retail;Food import and export;Drug import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Beijing Meilian Tailiao Biotechnology Co. Ltd. is a company headquartered in China. The firm manufactures and sells vitro diagnostic products. It was founded by Feng Li.

Wuxi Yishan Biotechnology Co., Ltd., established on 2017-11-10, Business scope includes medical devices,Technical development of diagnostic reagents,Technical Services,technical consulting,technology transfer;Ikind,IIProduction and sales of similar medical devices;Leasing of medical equipment(Excluding finance lease).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Szybio is engaged in the research and development, production, and sales of in vitro diagnostic reagents for clinical medicine. Their products and services include biochemical diagnostic reagent products, molecular diagnostic reagents, diagnostic testing-related equipment focusing on latex-enhanced immune turbidimetric technology products, and more.

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. Its products include fluorescent label protein, immune-checkpoint protein, and cytokine. The company was founded on July 22, 2010 and is headquartered in Beijing, China.

Sichuan Xincheng Biological Co., Ltd. is a private company headquartered in Chengdu, China. The firm manufactures vitro diagnostics products.

Shenzhen Berlot Biological Products Co., Ltd., established on 1999-01-26, Business scope includes general business items:Domestic Trade;Technical development of biological products;Operating import and export business(above according to the law,Administrative regulations,Decisions of the State Council and other regulations that require approval,Can only operate after obtaining relevant approval documents according to law).,The licensing program is:Operating medical devices;Production Class II,Class III6840In vitro diagnostic reagents;biologically active protein,antigenic protein,antibody protein,antigen enzyme-labeled protein,Research and development of antibody enzyme-labeled protein,production and sales.